These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 26940

  • 1. [Pharmacological inhibition of gastric secretion and treatment of peptic ulcer].
    Konturek SJ.
    Rev Esp Enferm Apar Dig; 1978 Apr 01; 53(1):65-82. PubMed ID: 26940
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacologic antagonists to gastric acid secretion.
    Dinoso VP.
    Compr Ther; 1978 Jul 01; 4(7):40-3. PubMed ID: 27329
    [No Abstract] [Full Text] [Related]

  • 3. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA.
    Acta Gastroenterol Latinoam; 1996 Jul 01; 26(4):263-5. PubMed ID: 9335935
    [No Abstract] [Full Text] [Related]

  • 4. Newer antisecretory agents for peptic ulcer.
    Somerville KW, Langman MJ.
    Drugs; 1983 Mar 01; 25(3):315-30. PubMed ID: 6133734
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Histamine H2 receptor antagonists. Notes on clinical pharmacology].
    Pelosio L, Marasco A, Naim U.
    Clin Ter; 1979 Nov 30; 91(4):421-7. PubMed ID: 44237
    [No Abstract] [Full Text] [Related]

  • 10. Peptic ulcer disease: physiology and pathophysiology.
    Holt KM, Isenberg JI.
    Hosp Pract (Off Ed); 1985 Jan 15; 20(1):89-93, 96-101, 104-6. PubMed ID: 2856923
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prostaglandins and gastrict secretion].
    Fabiano A, Cosen JN, Néstor J.
    Acta Gastroenterol Latinoam; 1978 Jan 15; 8(4):259-70. PubMed ID: 219654
    [No Abstract] [Full Text] [Related]

  • 13. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK, Mahakian K, Trudeau WT.
    Clin Pharm; 1986 Feb 15; 5(2):128-42. PubMed ID: 2869852
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of ulcer with a new antacid-antisecretive-antispastic combination].
    Castellazzi V, Marenco G, Ghibaudi D.
    Clin Ter; 1969 Apr 15; 49(1):47-61. PubMed ID: 4396961
    [No Abstract] [Full Text] [Related]

  • 16. Advances in the treatment of peptic ulcer disease.
    Camara DS.
    Compr Ther; 1987 Aug 15; 13(8):13-6. PubMed ID: 2887333
    [No Abstract] [Full Text] [Related]

  • 17. Interrelationships between histamine, prostaglandins, and cyclic AMP in gastric secretion: a hypothesis.
    Dousa TP, Dozois RR.
    Gastroenterology; 1977 Oct 15; 73(4 Pt 2):904-12. PubMed ID: 20385
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Mechanism of recurrence and relapse in peptic ulcer after drug therapy; gastric juice and gastric acid secretion].
    Nakaizumi A, Iishi H, Tatsuta M, Okuda S.
    Nihon Rinsho; 1988 Jan 15; 46(1):102-6. PubMed ID: 2897480
    [No Abstract] [Full Text] [Related]

  • 20. [Gastric secretion blockaders in peptic ulcer].
    Arutionian VM, Minasian GA.
    Sov Med; 1989 Jan 15; (7):45-8. PubMed ID: 2572058
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.